首页 › 基金 › Affinity Asset Advisors, LLC › ANAB
Affinity Asset Advisors, LLC 对 ANAB 的持仓历史
ANAPTYSBIO INC COM · 医疗保健
Affinity Asset Advisors, LLC 在 Q2 2026 的 13F 申报中披露持有 ANAB(ANAPTYSBIO INC COM)826,109 股,市值约 US$55.8M,约占其申报组合的 2.68%,在其申报持仓中市值排名第 9 位。 Affinity Asset Advisors, LLC 最近 8 个申报季度中有 4 个季度披露了 ANAB 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Affinity Asset Advisors, LLC 对 ANAB 的持仓演变
Affinity Asset Advisors, LLC 于 Q3 2024 首次披露 ANAB 持仓:200,000 股(约 US$6.7M)。 该持仓在 Q2 2026 达到峰值 826,109 股,市值约 US$55.8M。 在 4 次申报中,Affinity Asset Advisors, LLC 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 826,109 股、市值约 US$55.8M,环比减持 -113,891 股。。 持仓曾出现大幅变动:Q1 2026 增持约 111% (随后一个季度股价上涨 83%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 200.00K | $6.70M | 新进 |
| Q4 2025 | 444.69K | $21.56M | 新进 |
| Q1 2026 | 940.00K | $52.13M | 增持 |
| Q2 2026 | 826.11K | $55.76M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ANAB 与 13F 数据
ANAB(ANAPTYSBIO INC COM)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 ANAB,申报仓位最大的包括:EcoR1 Capital, LLC (US$531.9M), TANG CAPITAL MANAGEMENT LLC (US$89.8M), Sanofi (US$55.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANAB 的基金
- EcoR1 Capital, LLC 7.88M 股 · $531.91M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.33M 股 · $89.83M · Q2 2026
- Sanofi 821.92K 股 · $55.48M · Q2 2026
- 683 Capital Management, LLC 660.00K 股 · $44.55M · Q2 2026
- Palo Alto Investors LP 603.49K 股 · $40.74M · Q2 2026
- First Light Asset Management, LLC 582.00K 股 · $39.29M · Q2 2026
- APIS CAPITAL ADVISORS, LLC 497.00K 股 · $33.55M · Q2 2026
- Sofinnova Investments, Inc. 493.54K 股 · $33.31M · Q2 2026
- Coppell Advisory Solutions LLC 3.64K 股 · $16.58M · Q2 2026
- Greenhaven Road Investment Management, L.P. 171.06K 股 · $11.55M · Q2 2026
更多关于 Affinity Asset Advisors, LLC
常见问题
How long has Affinity Asset Advisors, LLC held ANAB?
Affinity Asset Advisors, LLC has disclosed ANAB holdings in 4 of the last 8 reported quarters, going back to Q3 2024.
What is Affinity Asset Advisors, LLC's current position in ANAB?
As of Q2 2026, Affinity Asset Advisors, LLC holds 826.11K shares of ANAB (ANAPTYSBIO INC COM), valued at $55.76M, representing 2.68% of its reported portfolio and ranking #9.
Has Affinity Asset Advisors, LLC been buying or selling ANAB?
In the latest 13F filing (Q2 2026), Affinity Asset Advisors, LLC reduced its position in ANAB. The position peaked in Q2 2026 at 826.11K shares.
Which other funds hold ANAB?
Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sanofi, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.